Option Care director granted 8,997 RSUs

Option Care Health director Barbara W. Bodem received an equity award of 8,997 common shares on May 20, 2026.

Rhea-AI Filing Summary

Option Care Health director Barbara W. Bodem received an equity award of 8,997 common shares on May 20, 2026. The award represents restricted stock units valued at $200,000 based on the issuer’s closing share price on that date and carries no cash exercise cost.

The restricted stock units vest in full on May 20, 2027, meaning Bodem must remain in service through that date to receive the underlying shares. Following this grant, she beneficially owns 21,087 common shares directly, according to the filing.

Insights

Equity compensation analyst

Director receives routine $200,000 RSU grant vesting in one year.

Director Barbara W. Bodem was granted 8,997 restricted stock units, valued at $200,000 using the May 20, 2026 closing price. The award is compensation, not a market purchase, and carries a zero exercise price.

The units vest fully on May 20, 2027, so value realization depends on her continued service and the share price at vesting. After the grant, she reports 21,087 common shares as directly owned, indicating this is a modest-scale, routine board compensation award.

Insider Trade Summary

Grant/Award: 8,997 shares

Grant/Award 1 txn

Insider Bodem Barbara W.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,997	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,087 shares (Direct)

Footnotes (1)

1. F1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Key Figures

RSUs granted: 8,997 shares Grant value: $200,000 Post-grant holdings: 21,087 shares +2 more

5 metrics

RSUs granted 8,997 shares Restricted stock units granted on May 20, 2026

Grant value $200,000 Value based on May 20, 2026 closing price

Post-grant holdings 21,087 shares Total common shares beneficially owned after transaction

Exercise price $0.0000 per share Stated price per share for the grant

Vesting date May 20, 2027 RSUs vest in full on this date

Key Terms

restricted stock units, vest in full, closing price, beneficially owns

4 terms

restricted stock units financial

"The reporting person received an award of restricted stock units on May 20, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest in full financial

"which vest in full on May 20, 2027"

closing price financial

"based on the closing price of the issuer's common stock on May 20, 2026"

beneficially owns financial

"total_shares_following_transaction": "21087.0000""

Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Option Care Health (OPCH) director receive in this Form 4 filing?

The filing shows director Barbara W. Bodem received 8,997 restricted stock units of Option Care Health common stock. The award represents equity-based compensation rather than a cash transaction, expanding her stake tied directly to the company’s future share performance.

How was the value of Barbara Bodem’s OPCH restricted stock unit grant determined?

The grant was designed to reflect $200,000 of value, calculated using the closing price of Option Care Health common stock on May 20, 2026. This links the award’s size directly to the market value on the grant date.

When do Barbara Bodem’s Option Care Health restricted stock units vest?

The restricted stock units granted to Barbara Bodem vest in full on May 20, 2027. She must remain eligible through that date to receive the underlying common shares, aligning her compensation with longer-term company performance and director service continuity.

How many Option Care Health shares does Barbara Bodem own after this Form 4 transaction?

After the reported grant, Barbara Bodem is shown as beneficially owning 21,087 shares of Option Care Health common stock directly. This total incorporates the new 8,997-share restricted stock unit award disclosed in the Form 4 insider transaction report.

Does this OPCH Form 4 indicate a market purchase or sale by the director?

The Form 4 records an equity award coded as an acquisition (grant), not an open-market purchase or sale. Barbara Bodem received 8,997 restricted stock units at a stated price of $0.0000 per share as part of her director compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 06:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bodem Barbara W.

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		8,997(1)	A	$0	21,087	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

	/s/ Michael Bavaro, attorney-in-fact for Ms. Bodem	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)